Motor neuron disease - PowerPoint PPT Presentation

About This Presentation
Title:

Motor neuron disease

Description:

Motor neuron disease Multiple sclerosis Motor neuron disease Motor pathway cortex motor area Corticospinal fiber & corticobulber ... – PowerPoint PPT presentation

Number of Views:297
Avg rating:3.0/5.0
Slides: 42
Provided by: hakeemsy
Category:
Tags: disease | motor | neuron

less

Transcript and Presenter's Notes

Title: Motor neuron disease


1
Motor neuron disease
2
Multiple sclerosis
3
Motor neuron disease
  • Motor neuron disease is degenerative disease
    which selectively affect motor tract fibers
  • (corticospinal tract anterior horn cell)
  • UMN signs LMN signs

4
Motor pathway
  • cortex motor area
  • Corticospinal fiber corticobulber
  • AHC motor neuron
    disease
  • Peripheral nerves
  • NMJ
  • muscle

5
pathology
  • Degeneration of the neurons

6
path physiology
  • Sporadic90 unclear
  • Inherted10 familial ALS,25 mutation in gene
    encoding copper zinc super oxide dismutase (SOD1)

7
course
  • Is progressive median survival is approximately
    3y

8
classification
  • Classic ALS (amyotrophic lateral
    sclerosis)..UMNLMN signs
  • others
  • Progressive muscular atrophy
  • Primary lateral sclerosis
  • Progressive bulbar palsy
  • Progressive pseudo bulbar palsy

9
Classic ALS
  • Mixed upper motor neuron upper motor neuron
    signs
  • Early patient may exhibit only LMN signs or
    upper LMN signs
  • Weakness begin a symmetrical and distally then
    spread to involve contiguous group of motor
    neurons
  • Bulbar pesudobulber palsy involvement
    ..dysphagea dysarthria

10
  • Nooooooooooo
  • Cognitive
  • Sensory
  • Ocular
  • Autonomic Sphincter dysfunction

11
diagnosis
  • El Escorial criteria for dx
  • Definitive
  • Probable
  • possible

12
Electrophysiological
  • NCS sensory..N
  • motornormal or dec amp
  • EMG denervation

13
treatment
  • Riluzole 50 mg bid ( extend tracheotomy free
    survival by 2-3 months, not improving the
    survival or muscle strength
  • Supportive care physiotherapy, respiratory,
    swallowing..

14
(No Transcript)
15
Diagram weakness approach
16
Multiple sclerosis
17
  • MS is the most disabling neurological condition
    of young adults

18
Epidemiology
  • Onset is typically in the mid 20s,although the
    dx may be delayed for several years
  • The ratio of f to m 1.77 to 1
  • The incidence of MS in blacks residing in the
    united states is about 25 that of whites
  • High incidence includes all of Europe,North
    america,New Zealand,southern austeralia but the
    incidence also increasing in middle east

19
pathophysiogy
  • Inflamatory rxn causes variable tissue damage
  • Destruction of myelin producing cells
    (oligodendrocytes
  • Some cells damaged without remyelination but
    oligodendrocytes precursors ..remyelinate..plaque

20
Risk factors
  • Genetic
  • Infection viral
  • autoimmune

21
genetic
  • In general in the united states, the prevalence
    of MS is about ,1
  • If a mother has MS,, her children's have a chance
    3-5 .
  • If father has MS, his son has a1 chance his
    daughter a 2 chance
  • Non identical twins has 3-4
  • Identical twins30

22
Clinical presentation
  • Relapsing remitting the commonest
  • (gtone attack in gtone site (multifocal)
  • Progressive relapsing
  • Primary progressive
  • Secondary progressive

23
diagnosis
  • Clinical typical relapses come on over a few
    days, lasts for weeks or months ,and then clear,
    over 80 of patients begin with relapses
  • All central nervous system can be affected
  • Typical relapses
  • A-optic neuritis
  • B-myelopathy(spinal cord)
  • C-brain stem cerebellar

24
  • Optic neuritis clouding or blurring of central
    vision in one eye
  • loss of measured activity, impair pupillary
    light reflex, some local pain made worse by eye
    movementusually full recovery
  • Myelopathy often sensory only numbness
    tingling from a certain level on the trunk on
    down through the rest of the body. if marked
    ..weakness
  • Brain stem

25
  • Each of these relapses may leave some residual
  • After several attacks of various types, a patient
    may present common deficit
  • Mild reduction in vision in one eye
  • No conjugate eye movements
  • Extensor planter responses inability to walk
    heel and toe
  • Reduced vibration sense in the legs
  • Urgency of bladder function

26
  • Late stage deficit include dementia, inability
    to stand or walk, slurred speech, ataxic,
    incontinence ,and marked sensory loss in hands
    legs

27
  • Lehrmit sign
  • Athoufs phenomena

28
Diagnostic workup
  • MRI

29
  • Mri is now the dominant laboratory method of
    diagnosis in MS
  • MS lesions are usually easily detected and often
    characteristic
  • Multiple bright lesion in T2
  • Contrast enhanced lesion
  • Shape ovoid
  • Sizegt5mm
  • Site adjacent to the lateral ventricles, corpus
    callosum, cerebellum

30
  • LP modest no of lymphocytes lt50/mm,total protein
    lt.8g/L,elevated immunoglobulin G(IgG), level
    oligoclonal banding on electrophoresis(80)
  • Evoked potentials VER,BAR,somatosensory evoked
    potential

31
diagnosis
  • McDonald criteria
  • Confirm lesion gtone site gt one attack

32
Diffrential diagnosis
  • Clinically
  • Multiple infarctions
  • Autoimmune diseases
  • Vascuilities behcets
  • Sarcidosis
  • Infection chronic meningitis

33
Diseases that cause similar MRI pictures
  • Vascular vascuilities,small vesseles
    disease,migraine
  • InfectionHIV.Lyme disease
  • Granulomtous sarcidosis
  • ADEM

34
Treatment
  • Definitive supportive

35
definitive
  • Six principles of management in multiple
    sclerosis
  • 1-relapses with significant impairment of
    function should be treated with high dose IV
    corticosteroid
  • 2-All relapsing remitting patients should be
    receiving long term immunomodulatory treatments
  • 3-Secondary progressive need aggressive tt
    early,late tt ltfew years little benefit

36
  • 4- primary progressive patients can not be
    expected to response to any tt
  • 5-multiple sclerosis is a life long disease ,no
    specific time when to discontinue tt once it
    started,if one modality of tt fail or not
    tolerated ,another medication shouled be tried
  • 6-patients need to be watched for signs of
    disease activity by clinical or magnetic
    resonance monitring or bothor both.

37
Drug used for long term management
  • Interferon B(avonex,betaseron,rebif..dec the
    risk of the attacks by 30(sc.IM)
  • Side effects
  • Depression,flu like,hepatitis
  • Copaxon
  • Widespread articaria

38
Other immunsuppretion
39
Drug for acute phase
  • Methylpredinsolone 1g iv for 5d
  • Side effects

40
Supportive care symptomatic)
  • Spasticity
  • Depression
  • Fatigue
  • Urinary urgency
  • pain

41
thanks
Write a Comment
User Comments (0)
About PowerShow.com